Christine Matthews, Chief Financial Officer at Zosano Pharma Corp (ZSAN), sold 82 shares at $0.71 ($58) on 2022-06-06, disclosed to the SEC on 2022-06-07.
Open-market sale of $58 ZSAN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |